Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The anti-inflammatory drug celecoxib is metabolized by Pseudomonas aeruginosa CYP107S1 in vitro and in vivo

Drug Metabolism and Disposition(2025)10.1016/j.dmd.2025.100184Source: DataRank Database

The anti-inflammatory drug celecoxib is metabolized by Pseudomonas aeruginosa CYP107S1 in vitro and in vivo is a research paper published in Drug Metabolism and Disposition (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.76)OA: hybridTopics (23)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Jed N. Lampe ORCID,Sylvie E. Kandel ORCID

Live enrichment

PubMed:41237685 PMC:PMC13095469 OpenAlex:https://openalex.org/W4415390493

National Institutes of Health National Institute of Allergy and Infectious Diseases

Grant: R01-AI176245

National Institutes of Health

FWCI

0.76

Citation Percentile

0.7%

Citation Trend

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.dmd.2025.100184

publisherhttps://doi.org/10.1016/j.dmd.2025.100184

publisherhttps://api.elsevier.com/content/article/PII:S0090955625094930?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0090955625094930?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41237685

Fields of Study

Inflammatory mediators and NSAID effectsPharmacogenetics and Drug MetabolismComputational Drug Discovery Methods

MeSH Terms

CelecoxibAnimalsAnti-Inflammatory Agents, Non-SteroidalCytochrome P-450 Enzyme SystemHumansMalePseudomonas aeruginosaCyclooxygenase 2 Inhibitors

Keywords

Pseudomonas aeruginosaMetaboliteCytochrome P450Drug metabolismIn vivoEnzymeMetabolismBacteroides thetaiotaomicronPathogenic bacteriaProbe SubstrateCelecoxib HydroxylationPseudomonas Aeruginosa Cyp107s1

The anti-inflammatory drug celecoxib is metabolized by Pseudomonas aeruginosa CYP107S1 in vitro and in vivo

FAIR Checklist

Authors (2)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)